Publications

Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma

 47
Histone methyltransferase PRDM9 promotes survival of drug-tolerant persister cells in glioblastoma

Tags:

Previous Article

Driver of cardiac injury after coronary microembolization

Next Article

How glioblastoma tumors dodge chemotherapy

Related Posts

Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance

Radiotherapy promotes cuproptosis and synergizes with c...

 131

Mechanisms governing lineage plasticity and metabolic reprogramming in cancer

Mechanisms governing lineage plasticity and metabolic r...

 97

A continuously oxygenated macroencapsulation system enables high- density packing and delivery of insulin- secreting cells

A continuously oxygenated macroencapsulation system en...

 117